Abstract: Nordy is a synthesized chrial compound. To investigate the effects of nordy (25-100 μmol·L^-1) on the function of formylpeptide receptor (FPR) of malignant human glioma cells, human glioblastoma cell line U87 was used to detect its proliferation, migration, calcium mobilization, vascular endothelial growth factor (VEGF) mRNA and protein levels after activation of FPR by its agonist n-formyl-methionyl-leucyl-phenylalanine (fMLF). Cell proliferation, migration ability, VEGF mRNA, VEGF protein and calcium mobilization were evaluated by cell counting, chemotaxis assay, RT-PCR, ELISA and spectrometry. Nordy (50-100 μmol·L^-1) potently inhibited the proliferation, migration and calcium mobilization of U87 cells induced by fMLF (P<0.05). Moreover, 100 μmol·L^-1 nordy showed a significantly impaired VEGF mRNA expression and protein secretion induced by fMLF (P<0.05). Nordy could inhibit FPR functioning in glioma cell proliferation, migration and angiogenesis, which might be a possible mechanism of its anti-cancer effects.